Business
United States Antimony Corporation Reports Third Quarter and Nine Months Ended September 30, 2025 Financial and Operating Results
Revenues Up 182% YOYGross Profit Up 219% YOY “The Critical Minerals and ZEO Company”~ Antimony, Cobalt, Tungsten, and Zeolite ~ DALLAS, TEXAS / ACCESS Newswire / November 12, 2025 / United States Antimony Corporation ("USAC," "US Antimony ...
About this update from United States Antimony Corporation
[{"type":"text","content":"Revenues Up 182% YOYGross Profit Up 219% YOY","length":45,"tagName":"p"},{"type":"text","content":"“The Critical Minerals and ZEO Company”~ Antimony, Cobalt, Tungsten, and Zeolite ~","length":103,"tagName":"p"},{"type":"text","content":"DALLAS, TEXAS / ACCESS Newswire / November 12, 2025 / United States Antimony Corporation ("USAC," "US Antimony Corporation," or the "Company"), (NYSE American:UAMY)(NYSE Texas:UAMY) reported today its third quarter and nine months ended September 30, 2025 financial and operational results.","length":320,"tagName":"p"},{"type":"text","content":"Revenues for the first nine months of 2025 increased to $26.23 million, or a 182% increase of $16.92 million, compared to $9.31 million for the first nine months of 2024 . During the same period, cost of revenues increased 170% or $11.96 million. This in-turn allowed the Company's gross profit to more than triple with an increase of 219%, or $4.96 million to $7.22 million as compared to $2.26 million during the same nine-month period in 2024. Gross margin increased to 28% during the first nine months of 2025 from a 24% margin experienced during the same nine months of last year. This 4% increase in gross margin is before processing any of USAC's in-house antimony recently mined in Montana. Operating expenses were $11.76 million for the first nine months of 2025, which is an increase of $8.19 million compared to the same period in the prior year.","length":865,"tagName":"p"},{"type":"text","content":"The Company incurred a net loss of $4.05 million for the nine months ended September 30, 2025, as compared to a net loss of $847k for the corresponding nine-month period in the prior year. Included in the net loss for 2025 was $5.18 million of non-cash expenses, which consisted primarily of $4.69 million of non-cash share-based compensation expense related to management and directors' stock grants that were expensed during this period after shareholder approval at the Company's annual meeting held on July 31, 2025, and $839k of non-cash depreciation and amortization expense.","length":589,"tagName":"p"},{"type":"text","content":"Our antimony sales were $23.57 million for the first nine months of 2025, which is up $16.5 million, or 235%, over last year. This improvement was primarily due to an incr...